Award
Delivery Order #SPE2DR26FMJU7
Short-Term Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FMJU7
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) umbrella, previously awarded to DMS Pharmaceutical Group Inc., a prominent pharmaceutical services provider. The contract entails the procurement and delivery of Midazolam Hydrochloride, a critical pharmaceutical product, to support agency healthcare needs. The delivery order, covering a brief multi-day period, is significant as it ensures timely access to essential medication, sustaining ongoing medical operations. The original IDV contract was competitively awarded, enhancing procurement efficiency and reliability. This particular transaction builds upon the long-term partnership with DMS Pharmaceutical Group, reinforcing the agency's pharmaceutical supply chain for the foreseeable future.
Description
4571140572! MIDAZOLAM HYDROCHLORI